We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
AusPAR: Xeljanz
Australian Public Assessment Report
Device/Product Name
Xeljanz
Active ingredients
Tofacitinib
AusPAR Date
Published
Sponsor
Submission Number
PM-2021-04843-1-3
Submission Type
Extension of indications
Decision
Approved